Add Yahoo as a preferred source to see more of our stories on Google. Sore, stiff joints are more than just a nuisance. When pain flares up, it can sometimes make even simple tasks like driving or ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’re one of the millions of people dealing with psoriatic arthritis, you know just how frustrating it can be. One day, you’re ...

Of all the people who have psoriasis - estimated to be about two percent of the US, according to Johns Hopkins - roughly one third of them will also develop psoriatic arthritis (PsA). That means ...

Psoriatic arthritis (PsA) is often misunderstood, and those misconceptions can make it harder for people to recognize symptoms, seek care, or understand what living with the condition is really like.

Psoriatic arthritis is a progressive, inflammatory condition that affects your joints and areas of the body where connective tissue meets bone. Because psoriatic arthritis is tied to your immune ...

People with psoriatic arthritis (PsA) often take medicines to help manage their condition and improve their symptoms. Some of these medicines work directly on the body's immune system and help to ...

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

A history of depression was the most predictive factor for developing persistent joint pain among patients with psoriatic arthritis. Treatment advances in PsA have allowed many patients to achieve ...

While joint pain and stiffness can impact your sleep, setting yourself up for quality rest each night can actually help improve your psoriatic arthritis symptoms. Joint pain. Itchy skin. Swelling in ...

It varies depending on the study and the cohort you are looking at. When you look at all studies that try to assess the presence of fibromyalgia in patients with various rheumatic diseases, it ranges ...

The FDA has approved a label expansion for the interleukin-23 inhibitor guselkumab to include the inhibition of structural ...